{"id":71192,"date":"2017-11-08T13:33:04","date_gmt":"2017-11-08T13:33:04","guid":{"rendered":"http:\/\/humanitasnet-new.local\/malattie\/lobularni-karcinom-dojke-in-situ\/"},"modified":"2025-01-13T02:54:32","modified_gmt":"2025-01-13T02:54:32","slug":"lobularni-karcinom-dojke-in-situ","status":"publish","type":"disease","link":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/","title":{"rendered":"Lobularni karcinom dojke in situ"},"content":{"rendered":"<h2 id=\"definicija\">Definicija<\/h2>\n<p>Lobularni karcinom dojke in situ (engl. skra\u0107. LCIS) je retko stanje koji se karakteri\u0161e rastom abnormlanih \u0107elija. Abnormalne \u0107elije razmno\u017eavaju se u re\u017enjevima (lobusima) dojke. Ovo stanje samo po sebi nije rak, ali ukoliko osoba ima dijgnozu LCIS to zna\u010di da je kod te osobe znatno pove\u0107an rizik od dobijanja raka dojke.<\/p>\n<p>Lobularni karcinom in situ obi\u010dno se ne mo\u017ee primetiti na mamogramu. \u010cesto se LCIS otkriva nakon biopsije dojke u cilju provere nekog drugog stanja, poput izrasline na dojci ili nejasnog mamograma.<\/p>\n<p>\u017dene kod kojih je LCIS dijagnostikovan imaju ve\u0107i rizik od nastanka invazivnog raka dojke. Za njih je preporu\u010dljivo redovno pra\u0107enje stanja i razmatranje nekih metoda le\u010denja koje \u0107e smanjiti rizik od nastanka raka dojke.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"simptomi\">Simptomi<\/h2>\n<p>Ne postoje simptomi koji se vezuju za lobularni karcinom in situ. Ovo stanje obi\u010dno pro\u0111e bez vidljivih znakova. Naj\u010de\u0161\u0107e se otkriva ispitivanjem nekih drugih abnormalnih pojava u ovom delu tela.<\/p>\n<p>Me\u0111utim, ukoliko se primeti bilo kakva promena na grudima (kvrga, nabor, zadebljala ko\u017ea ili iscedak bradavice), bilo bi dobro posetiti lekara.<\/p>\n<p>Rutinski skrining na rak dojke trebalo bi uzeti u razmatranje, kako bi se pratile i dr\u017eale pod nadzorom sve mogu\u0107e promene.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"uzroci\">Uzroci<\/h2>\n<p>Nije sasvim poznato \u0161ta dovodi do nastanka lobularnog karcinoma in situ. Formira se zbog genetske mutacije \u0107elija u lobulima grudi u kojima se proizvodi mleko. \u0106elije menjaju strukturu, postaju abnormalne i ostaju u lobusu, na mestu (in situ). \u0106elije se ne \u0161ire i ne napadaju ostatak tkiva dojki. LCIS se ne pretvara u rak, ali pove\u0107ava rizik od dobijanja raka. Neke statistike ukazuju na to da se taj rizik kod \u017eena koje imaju LCIS pove\u0107ava za \u010dak 20%. \u0160to zna\u010di, od 100 \u017eena sa dijagnozom LCIS, njih 20 \u0107e dobiti rak dojke. Me\u0161utim, svaka \u017eena ima individualni rizik od dobijanja raka dojke, koji opet zavisi od mnogih faktora.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"faktori-rizika\">Faktori rizika<\/h2>\n<p>Rizik dobijanja LCIS mo\u017ee da se pove\u0107a iz slede\u0107ih razloga:<\/p>\n<p>Porodi\u010dna istorija oboljevanja-Ukoliko su neki od bliskih\u00a0\u010dlanova porodice imali rak dojke, rizik za dobijanje LCIS je ve\u0107i.<\/p>\n<p>Zamenska hormonska terapija-ukoliko \u017eene koriste hormonsku terapiju tokom menopauze du\u017ee od 3 do 5 godina, rizik od dobijanja LCIS se pove\u0107ava.<\/p>\n<p>Starosna dob-ve\u0107ina \u017eena obolelih od LCIS je u ranim 40-im godinama, ili starije.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"lecenje\">Le\u010denje<\/h2>\n<p>Kada se odlu\u010duje o na\u010dinu le\u010denja lobularnog karcinoma in situ, trebalo bi uzeti u obzir nekoliko faktora, kao i same osobine pacijenta.<\/p>\n<p>Pristupi u le\u010denju mogu biti slede\u0107i: pra\u0107enje, le\u010denje ili hirur\u0161ki zahvat.<\/p>\n<p>Pa\u017eljivo pra\u0107enje uz \u010desto testiranje na bilo koje znake raka preko: redovnih samopregleda dojke, klini\u010dkih pregledi dojke dva puta godi\u0161nje, godi\u0161njeg skrininga i drugih metoda pregleda poput magnetne rezonance.<\/p>\n<p>Jo\u0161 jedan tip le\u010denja je i preventivno uzimanje lekova kako bi se smanjio rizik dobijanja raka dojke.<\/p>\n<p>Kona\u010dno, kao jedna od opcija je i uklanjanje LCIS hirur\u0161kim putem. LCIS mo\u017ee da se ukloni tokom biopsije ili nekog dodatnog zahvata ukoliko se ve\u0107 otklanja odre\u0111eni deo nekog tkiva u blizini. I dalje \u0107e biti potrebni redovni pregledi i kontrole, budu\u0107i da rizik do dobijanja raka ostaje. Tako\u0111e postoji i mogu\u0107nost za preventivnu mastektomiju tokom koje se obe dojke uklone u cilju smanjenja rizika koji u nekim slu\u010dajevima postoji.<\/p>\n<p>&nbsp;<\/p>\n<p>Neke preventivne more koje mo\u017eemo provesti sami za smanjenje rizika:<\/p>\n<p>Ograni\u010dena upotreba alkohola na jedno pi\u0107e dnevno ili potpuno izbacivanje alkohola iz upotrebe<\/p>\n<p>Odr\u017eavanje normalne telesne te\u017eine<\/p>\n<p>Manji unos kalorija<\/p>\n<p>Ve\u017ebanje najmanje 30 minuta dnevno tokom \u0161to vi\u0161e dana u nedelji.<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-71192","disease","type-disease","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lobularni karcinom dojke in situ - Humanitas.net<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"sr_RS\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lobularni karcinom dojke in situ - Humanitas.net\" \/>\n<meta property=\"og:description\" content=\"Definicija Lobularni karcinom dojke in situ (engl. skra\u0107. LCIS) je retko stanje koji se karakteri\u0161e rastom abnormlanih \u0107elija. Abnormalne \u0107elije razmno\u017eavaju se u re\u017enjevima (lobusima) dojke. Ovo stanje samo po sebi nije rak, ali ukoliko osoba ima dijgnozu LCIS to zna\u010di da je kod te osobe znatno pove\u0107an rizik od dobijanja raka dojke. Lobularni karcinom [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/\" \/>\n<meta property=\"og:site_name\" content=\"Humanitas.net\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HumanitasInternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T02:54:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@humanitasmilano\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/\",\"name\":\"Lobularni karcinom dojke in situ - Humanitas.net\",\"isPartOf\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\"},\"datePublished\":\"2017-11-08T13:33:04+00:00\",\"dateModified\":\"2025-01-13T02:54:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/#breadcrumb\"},\"inLanguage\":\"sr-RS\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Malattie\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Lobularni karcinom dojke in situ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"name\":\"Humanitas.net\",\"description\":\"Humanitas Hospital\",\"publisher\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sr-RS\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\",\"name\":\"Humanitas\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"contentUrl\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"width\":1,\"height\":1,\"caption\":\"Humanitas\"},\"image\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/HumanitasInternational\/\",\"https:\/\/x.com\/humanitasmilano\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lobularni karcinom dojke in situ - Humanitas.net","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"sr_RS","og_type":"article","og_title":"Lobularni karcinom dojke in situ - Humanitas.net","og_description":"Definicija Lobularni karcinom dojke in situ (engl. skra\u0107. LCIS) je retko stanje koji se karakteri\u0161e rastom abnormlanih \u0107elija. Abnormalne \u0107elije razmno\u017eavaju se u re\u017enjevima (lobusima) dojke. Ovo stanje samo po sebi nije rak, ali ukoliko osoba ima dijgnozu LCIS to zna\u010di da je kod te osobe znatno pove\u0107an rizik od dobijanja raka dojke. Lobularni karcinom [&hellip;]","og_url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/","og_site_name":"Humanitas.net","article_publisher":"https:\/\/www.facebook.com\/HumanitasInternational\/","article_modified_time":"2025-01-13T02:54:32+00:00","twitter_card":"summary_large_image","twitter_site":"@humanitasmilano","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/","name":"Lobularni karcinom dojke in situ - Humanitas.net","isPartOf":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website"},"datePublished":"2017-11-08T13:33:04+00:00","dateModified":"2025-01-13T02:54:32+00:00","breadcrumb":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/#breadcrumb"},"inLanguage":"sr-RS","potentialAction":[{"@type":"ReadAction","target":["https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/lobularni-karcinom-dojke-in-situ\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/"},{"@type":"ListItem","position":2,"name":"Malattie","item":"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/"},{"@type":"ListItem","position":3,"name":"Lobularni karcinom dojke in situ"}]},{"@type":"WebSite","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website","url":"https:\/\/humanitas-net.humweb.webiz.team\/","name":"Humanitas.net","description":"Humanitas Hospital","publisher":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sr-RS"},{"@type":"Organization","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization","name":"Humanitas","url":"https:\/\/humanitas-net.humweb.webiz.team\/","logo":{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","contentUrl":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","width":1,"height":1,"caption":"Humanitas"},"image":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HumanitasInternational\/","https:\/\/x.com\/humanitasmilano"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/disease\/71192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/disease"}],"about":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/types\/disease"}],"wp:attachment":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/media?parent=71192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}